Who are the peers of the Beta Drugs Ltd?
Beta Drugs Ltd's peers include SMS Pharma, Amrutanjan Health, Windlas Biotech, and others. It has good growth prospects and an excellent capital structure, with a 1-year return of 39.87%, outperforming Hester Bios but trailing Jagsonpal Pharma's 67.26%.
Peers: The peers of Beta Drugs Ltd are SMS Pharma., Amrutanjan Healt, Windlas Biotech, Syncom Formul., Bajaj Healthcare, Jagsonpal Pharma, Bliss GVS Pharma, Hester Bios, Sigachi Indust., and Anuh Pharma.Quality Snapshot: Excellent management risk is observed at Amrutanjan Healt and Bajaj Healthcare, while Average management risk is found at SMS Pharma., Windlas Biotech, Syncom Formul., Beta Drugs Ltd, Jagsonpal Pharma, Bliss GVS Pharma, Hester Bios, Sigachi Indust., and Anuh Pharma. Growth is rated as Good for Beta Drugs Ltd, Bajaj Healthcare, and Jagsonpal Pharma, while Below Average growth is noted for SMS Pharma., Amrutanjan Healt, Windlas Biotech, Syncom Formul., Bliss GVS Pharma, Hester Bios, and Sigachi Indust. Capital Structure is Excellent for Amrutanjan Healt, Windlas Biotech, Syncom Formul., Beta Drugs Ltd, Jagsonpal Pharma, Bliss GVS Pharma, Sigachi Indust., and Anuh Pharma, while Average capital structure is seen at SMS Pharma. and Bajaj Healthcare, and Below Average at Hester Bios.
Return Snapshot: The peer with the highest 1-year return is Jagsonpal Pharma at 67.26%, while the lowest is Hester Bios at -35.05%. Beta Drugs Ltd has a 1-year return of 39.87%, which is significantly higher than Hester Bios but lower than Jagsonpal Pharma. Additionally, the six-month return is negative for Hester Bios, Sigachi Indust., and Anuh Pharma.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
